Genesystem Co., Ltd. (KOSDAQ:363250)
South Korea · Delayed Price · Currency is KRW 3,985.00
-65.00 (-1.60%)
At close: Oct 23, 2026
Genesystem Market Cap
Genesystem has a market cap or net worth of 33.02 billion as of October 23, 2026. It is the 35,196th most valuable company in the world and the 2,075th biggest in South Korea. Its market cap has decreased by 21.41% in one year.
Market Cap
33.02B
Enterprise Value
31.93B
Revenue
1.01B
Global Rank
Country Rank
#2,075 South Korea
PE Ratio
n/a
ChartMarket Cap Chart
Since May 26, 2021, Genesystem's market cap has decreased from 118.51B to 33.02B, a decrease of -72.14%. That is a compound annual growth rate of -21.03%.
| Date | Market Cap | % Change |
|---|---|---|
| Oct 23, 2026 | 33.02B | 18.08% |
| Dec 30, 2025 | 27.96B | -52.89% |
| Dec 30, 2024 | 59.36B | -8.92% |
| Dec 28, 2023 | 65.17B | 12.35% |
| Dec 29, 2022 | 58.00B | -26.36% |
| Dec 30, 2021 | 78.77B | -33.54% |
| May 26, 2021 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| SELVAS Healthcare | 58.64B |
| DRGEM | 53.44B |
| Dynamic solution | 48.75B |
| QuantaMatrix | 42.79B |
| Genoray | 39.66B |
| JPI Healthcare | 38.60B |
| BTB Korea Co.,Ltd | 35.97B |
| UXN Co., Ltd. | 30.61B |